Patient engagement in a clinical trial is more than recruitment. It includes how people learn about a study, decide whether to participate, navigate study activities, communicate concerns, and receive appropriate follow-up. Effective engagement respects autonomy: participation must be informed and voluntary, and people must be able to decline or withdraw under the study’s consent terms without pressure.
Research on participant perspectives identifies recurring barriers such as unclear information, language barriers, time and travel burden, privacy concerns, and mistrust. Strategies should therefore address the specific study and community—not treat participants as a recruitment target or promise that any tactic will increase enrollment or retention.
1. Involve patients and communities early
Invite people with relevant lived experience, caregivers where appropriate, and community partners to review study materials and procedures while changes are still possible. Ask what is confusing, inconvenient, inaccessible, or likely to affect trust. Clarify the role of patient partners, compensate their expertise fairly under organizational policy, and explain which recommendations can be acted on.
2. Explain the study in clear, balanced language
Describe the research question, what participation involves, foreseeable risks and potential benefits, alternatives, costs or compensation, privacy protections, and whom to contact. Explain randomization, placebo or comparator groups, and uncertainty when relevant. Do not imply that an investigational product is proven to work or that participation will provide personal medical benefit.
Use the IRB/ethics-committee-approved consent process and materials. Offer qualified interpretation and accessible formats as needed. Allow time for questions and deliberation; check understanding respectfully rather than using a quiz to pressure someone into agreement. Research consent is an ongoing process, not just a signed form.
3. Identify and reduce avoidable participation burden
Map each study activity from screening through follow-up. Ask participants and site staff which visits, forms, procedures, travel, scheduling windows, or technology steps are most difficult. Where scientifically and ethically appropriate—and only through the required protocol and ethics review—consider less burdensome options, flexible scheduling, remote contacts, local services, transportation support, or simpler data collection.
Do not remove procedures required to answer the research question or protect participant safety without appropriate scientific, regulatory, and ethics review. A more convenient design still needs reliable data, safety monitoring, and clear procedures for urgent concerns.
4. Make communication predictable and two-way
- Give participants a named study contact and explain when and how to reach the team.
- Set expectations for visit timing, reminders, results communication, and what happens if a participant misses an activity.
- Use participants’ preferred and approved communication channels while protecting confidentiality.
- Invite questions and feedback throughout the study, not only at enrollment or closeout.
- Explain what the team can and cannot share, including limits on individual results and timing of study-wide findings.
5. Build trust through respectful, consistent conduct
Introduce study staff and their roles, distinguish research from individualized clinical care, and be transparent about sponsorship and conflicts as required. Avoid coercion, misleading claims, and recruitment messages that overstate benefits or understate risk. Respond to concerns promptly, document and escalate safety issues through the protocol, and respect a participant’s decision to stop.
